250,000 Shares in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACCU) Purchased by Affinity Asset Advisors LLC

Affinity Asset Advisors LLC bought a new stake in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACCU) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm bought 250,000 shares of the company’s stock, valued at approximately $2,538,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. ADAR1 Capital Management LLC bought a new stake in shares of Oaktree Acquisition Corp. III Life Sciences during the 4th quarter worth $5,065,000. Kepos Capital LP acquired a new position in Oaktree Acquisition Corp. III Life Sciences during the fourth quarter worth about $709,000. Athos Capital Ltd bought a new position in shares of Oaktree Acquisition Corp. III Life Sciences in the fourth quarter worth about $507,000. Finally, Rangeley Capital LLC acquired a new stake in shares of Oaktree Acquisition Corp. III Life Sciences in the 4th quarter valued at approximately $101,000.

Oaktree Acquisition Corp. III Life Sciences Stock Performance

Shares of Oaktree Acquisition Corp. III Life Sciences stock opened at $10.26 on Tuesday. The firm’s 50 day moving average is $10.25. Oaktree Acquisition Corp. III Life Sciences has a 1 year low of $9.99 and a 1 year high of $10.60.

Oaktree Acquisition Corp. III Life Sciences Profile

We are a newly organized blank check company incorporated on June 28, 2024, as a Cayman Islands exempted company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination.